GPX4 and lung carcinoma: Prior investigations into ferroptosis in lung cancer have largely focused on regulators like GPX4 or SLC7A11 [47]; in contrast, our work captures a broader ferroptosis-linked transcriptomic signature with direct prognostic implications.